|
Acomplia / Zimulti (Rimonabant, Rimonbant)
- a hot new diet pill from Sanofi Aventis!
|
This
Rimonbant's got its market position in weight loss pill market... |
|
|
|
Remarks
- Sales in Europe in year 2006?
- $313M for Xenical, $197M for Meridia, $50M for
Axokine and $250M for Acomplia. We can see that
Acomplia is a new star and will take more market
shares soon!
- Learn more about Acomplia?
- Acomplia (Rimonbant) is a diet pill which
is effective in weight loss and available to order
and buy online. The Generic name for Acomplia is
Rimonbant. It is available in a 20mg diet pill which
is generally advised to be taken once a day usually
before breakfast.
- The band name Acomplia (Rimonbant) is
used in Europe for Rimonbant; however the US will
use the name Zimulti (Rimonbant) if the drug enters
the US market.
- Acomplia (Rimonbant) has been approved
for sale in all 25 countries of the European Union
by the European Commission. Acomplia (Rimonbant) is
to be used to treat obesity and assist weight loss
in people with a Body Mass Index (BMI) of 30 and
above.
- According to Sanofi CEO Jean-François Dehecq, the
people most likely to
benefit the most from Acomplia are "obese
patients with serious metabolic
and cardiometabolic risks."
- "The approval of Rimonabant Acomplia in the
European Union is important
news for obese and overweight patients with
additional cardiometabolic risk
factors such as type 2 diabetes or dyslipidaemia who
will now have access
to an innovative treatment option,” said Sanofi
CEO Jean-François Dehecq.
- Acomplia (Rimonabant) was first available
to buy in the United Kingdom. Acomplia (Rimonabant)
is now available in Argentina, Austria, Norway,
Finland, Sweden, Denmark, Ireland and Germany.
- In February 2006 the U.S. Food and Drug
Administration (FDA) issued Acomplia (Rimonabant)
with an approval letter. However, there were some
concerns which Santofi needed to address before the
medication was allowed onto the market. These were
completed on October 31 2006.
- An FDA will meet on June 13th to discuss "the
efficacy and safety of new drug application (NDA)
21-888, proposed trade name Zimulti (Rimonabant)."
The results of this meeting will also be aired on
June 13th.
- It is speculated that the outcome of the FDA panel
discussion will be the
approval of Zimulti (Rimonabant) in the US.
|
- Rimonabant's synonyms may be?
- Brand name of Rimonbant from Sanofi-Aventis is Acomplia (20mg). There are also some other generic product brands on the market: SR141716, Acomplia, Bethin, Monaslim, Remonabent, Riobant, Rimoslim, Riomont, Slimona, and Zimulti.
|
|
|
